Page 3 - Shaun Bagai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Clinical Data Abstract Presentation; IP Portfolio of 9 Patents; Phase 3 Cancer Treatments: RenovoRx NASDAQ: RNXT $RNXT

Clinical Data Abstract Presentation; IP Portfolio of 9 Patents; Phase 3 Cancer Treatments: RenovoRx NASDAQ: RNXT $RNXT
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

United statesSalt lake cityFrance generalMichaelj pishvaianShaun bagaiGustave roussyFrontpagestocks corporateadsShripal gandhiMichel ducreuxResearch supports renovorx lead oncology productRenovorx incImugene ltdMiami cancer instituteUniversity of paris sudData monitoring committeeGastrointestinal tract cancer group

RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting

RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSalt lake cityJack perkinsMichel accadShaun bagaiRenovorx incSecurities exchangeNasdaq stock marketSociety of interventional radiologyStrategic communicationsResearch supports renovorx lead oncology productExchange commissionResearch supports renovorxLead oncology product candidateNovel therapy platformLocally advanced pancreatic

RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform

RenovoRx Holds a Strong Intellectual Property Portfolio with 9 Issued Patents for its Proprietary Trans-Arterial Micro-Perfusion Therapy Platform and Delivery System New Patent Would Expand IP.

Shaun bagaiCompany phase iii tiger paExchange commissionRenovorx incSecurities exchangeData monitoring committeePatent cooperation treatyTrans arterial micro perfusionLocally advanced pancreatic cancerOverall survivalDrug evaluationSecurities actSecurities exchange actR pac phase

RenovoRx (RNXT) Appoints Michel Ducreux to its Board

RenovoRx (RNXT) Appoints Michel Ducreux to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalMichel ducreuxShaun bagaiGustave roussyCompany scientific advisory boardUniversity of paris sudEuropean organisation for researchRenovorx incGastrointestinal tract cancer groupSaclay universityScientific advisory boardGastrointestinal oncology unitGastrointestinal oncology tumor boardParis saclay universityPaul brousse hospitalMedical affairs director

RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M D , Ph D

RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing targeted combination therapies, today announced the appointment of Michel Ducreux, M.D., Ph.D. to the Company’s Scientific.

France generalShaun bagaiMichel ducreuxGustave roussyGastrointestinal tract cancer groupEuropean organisation for researchExchange commissionSecurities exchangeCompany nasdaqSaclay universityRenovorx incUniversity of paris sudCompany scientific advisory boardScientific advisory boardGastrointestinal oncology unitGastrointestinal oncology tumor board